Company* (Country; Symbol) Company* (Country; Symbol) Type/Product Area Terms/Details (Date)

Agilent Technologies Inc. (NYSE:A)  Signature Genomic Laboratories LLC* Long-term agreement in which Agilent will supply custom oligonucleotide  microarrays based on the Signature-designed Signature Chip Oligo Solution for the detection of chromosome abnormalities in individuals with mental retardation/development delay, autism and congenital anomalies Further terms were not disclosed (5/15)
 
CuraGen Corp. (CRGN) TopoTarget A/S (Denmark; CSE: TOPO) Agreement for CuraGen to sell its cancer drug  belinostat TopoTarget will takeover the product for $26M in cash and $5M in shares, as well as $6M in milestone payments related to future net sales and sublicenses; Topo-Target plans to move the product into a Phase III trial for patients with peripheral T-cell lymphoma (4/22)
 
Sequenom Inc. (SQNM) Invitrogen Corp. (IVGN) Agreement under which Invitrogen will be the exclusive distributor for Sequenom's MassARRAY systems and consumable products in Central and South America Financial terms were not disclosed (5/1)

Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

CSE = Copenhagen Stock Exchange; NYSE = New York Stock Exchange.